Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients’ Perspectives
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients’ Perspectives
Authors
Keywords
-
Journal
CNS DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-18
DOI
10.1007/s40263-021-00839-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Everolimus in adult tuberous sclerosis complex patients with epilepsy: Too late for success? A retrospective study
- (2021) Jakob Stockinger et al. EPILEPSIA
- The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
- (2021) Wolfgang Löscher et al. CNS DRUGS
- Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literature
- (2021) Johann Philipp Zöllner et al. Orphanet Journal of Rare Diseases
- Epidemiology, healthcare resource use, and mortality in patients with tuberous sclerosis complex: A population-based study on German health insurance data
- (2021) Adam Strzelczyk et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)
- (2020) Johann Philipp Zöllner et al. Orphanet Journal of Rare Diseases
- Prévalence de la sclérose tubéreuse de Bourneville chez des patients pris en charge pour un angiomyolipome rénal
- (2020) P. Maulaz et al. PROGRES EN UROLOGIE
- Developmental outcomes in children/adolescents and one adult with tuberous sclerosis complex (TSC) and refractory epilepsy treated with everolimus
- (2020) Navah E. Kadish et al. EPILEPSY & BEHAVIOR
- Cenobamate for the treatment of focal epilepsies
- (2020) Adam Strzelczyk et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex
- (2020) Takashi Hatano et al. International Journal of Clinical Oncology
- Prevalence, mortality and healthcare economic burden of tuberous sclerosis in Hong Kong: a population-based retrospective cohort study (1995–2018)
- (2020) William Ching-Yuen Chu et al. Orphanet Journal of Rare Diseases
- Quality of life and correlating factors in children, adolescents with epilepsy, and their caregivers: A cross-sectional multicenter study from Germany
- (2019) Janna Riechmann et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany
- (2019) Adam Strzelczyk et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex
- (2019) Catherine L. Salussolia et al. Annual Review of Genomics and Human Genetics
- Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age – a multicenter retrospective study
- (2019) Afshin Saffari et al. Orphanet Journal of Rare Diseases
- Off-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature
- (2019) M. Bevacqua et al. PEDIATRIC DRUGS
- A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany
- (2019) Adam Strzelczyk et al. EPILEPSIA
- Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus
- (2019) Laurent Maximilian Willems et al. EXPERT OPINION ON PHARMACOTHERAPY
- First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study
- (2019) Katja Menzler et al. BMJ Open
- Language predictors of autism spectrum disorder in young children with tuberous sclerosis complex
- (2019) Alexandra Schoenberger et al. EPILEPSY & BEHAVIOR
- Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature
- (2018) Alfonso Martínez-García et al. CARDIOLOGY IN THE YOUNG
- Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus
- (2018) Adam Strzelczyk et al. EPILEPSIA
- The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: Current evidence and future perspectives
- (2018) Susanne Schubert-Bast et al. EPILEPSY & BEHAVIOR
- How do parents perceive adverse drug events of their children's anticonvulsant medication?
- (2018) V.A. Bach et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience
- (2018) Darcy A. Krueger et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations
- (2018) Paolo Curatolo et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies
- (2018) D.N. Franz et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study
- (2018) Yongzhong Zhan et al. Orphanet Journal of Rare Diseases
- Topical Sirolimus to Treat Tuberous Sclerosis Complex (TSC)
- (2018) Thomas N. Darling JAMA Dermatology
- Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan
- (2018) Masashi Mizuguchi et al. BRAIN & DEVELOPMENT
- Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series
- (2018) Li Zhou et al. Orphanet Journal of Rare Diseases
- Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
- (2018) Laurent M. Willems et al. Frontiers in Neurology
- Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents
- (2018) Susanne Schubert-Bast et al. EPILEPSY & BEHAVIOR
- Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
- (2017) Isabel Steinig et al. EPILEPSIA
- Influence of seizures on early development in tuberous sclerosis complex
- (2017) Jamie K Capal et al. EPILEPSY & BEHAVIOR
- TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review
- (2017) Clévia Rosset et al. GENETICS AND MOLECULAR BIOLOGY
- Everolimus for the Treatment of Tuberous Sclerosis Complex–Related Cardiac Rhabdomyomas in Pediatric Patients
- (2017) Nagib Dahdah JOURNAL OF PEDIATRICS
- Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Marianne E Pavel et al. LANCET ONCOLOGY
- Pelvic lymphangioleiomyomatosis treated successfully with everolimus
- (2017) Sharjil Wahid et al. MEDICINE
- Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide
- (2017) Mark Davies et al. Orphanet Journal of Rare Diseases
- Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus
- (2017) Monica S. Arroyo et al. PEDIATRIC NEUROLOGY
- Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence
- (2017) Laurent M. Willems et al. Expert Review of Clinical Pharmacology
- Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study
- (2017) John J. Bissler et al. PLoS One
- Weighted false discovery rate controlling procedures for clinical trials
- (2016) Yoav Benjamini et al. BIOSTATISTICS
- Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysis
- (2016) Daniel B. Hawcutt et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled Clinical Trial
- (2016) Sergiusz Jóźwiak et al. JOURNAL OF PEDIATRICS
- Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
- (2016) Jacqueline A French et al. LANCET
- Efficacy and safety of Everolimus in children with TSC - associated epilepsy – Pilot data from an open single-center prospective study
- (2016) Sharon Samueli et al. Orphanet Journal of Rare Diseases
- Accelerated Cardiac Rhabdomyoma Regression with Everolimus in Infants with Tuberous Sclerosis Complex
- (2016) Fatou Aw et al. PEDIATRIC CARDIOLOGY
- Long-term Clinical Morbidity in Patients With Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
- (2016) John Bissler et al. UROLOGY
- Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus
- (2016) Adam Strzelczyk et al. Expert Review of Clinical Pharmacology
- Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
- (2016) David N. Franz et al. PLoS One
- Everolimus for subependymal giant cell astrocytoma: 5-year final analysis
- (2015) David N. Franz et al. ANNALS OF NEUROLOGY
- Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany
- (2015) Janna Riechmann et al. EPILEPSIA
- Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus
- (2015) Neera Nathan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus
- (2015) Adam Strzelczyk et al. Expert Review of Clinical Pharmacology
- Discussion: An estimate of the science-wise false discovery rate and applications to top medical journals by Jager and Leek
- (2013) Y. Benjamini et al. BIOSTATISTICS
- Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex
- (2013) A. M. Cappellano et al. CHILDS NERVOUS SYSTEM
- Everolimus in tuberous sclerosis patients with intractable epilepsy: A treatment option?
- (2013) Gert Wiegand et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
- (2013) D. A. Krueger et al. NEUROLOGY
- Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Hope Northrup et al. PEDIATRIC NEUROLOGY
- Tailoring mTOR-based therapy: molecular evidence and clinical challenges
- (2013) Gaetano Santulli et al. PHARMACOGENOMICS
- Evaluation of health-care utilization among adult patients with epilepsy in Germany
- (2012) Adam Strzelczyk et al. EPILEPSY & BEHAVIOR
- Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
- (2011) Francis X. McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regression of a Cardiac Rhabdomyoma in a Patient Receiving Everolimus
- (2011) D. Tiberio et al. PEDIATRICS
- Everolimus
- (2011) Monique P. Curran PEDIATRIC DRUGS
- Comparative Analysis of Adverse Events Requiring Suspension of mTOR Inhibitors: Everolimus versus Sirolimus
- (2010) A.I. Sánchez-Fructuoso et al. TRANSPLANTATION PROCEEDINGS
- The natural history of epilepsy in tuberous sclerosis complex
- (2009) Catherine J. Chu-Shore et al. EPILEPSIA
- Strategies to detect adverse effects of antiepileptic drugs in clinical practice
- (2008) M. Carreño et al. EPILEPSY & BEHAVIOR
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started